How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
A molecular geneticist at Montana State University has discovered a cellular process once believed impossible by ...
You might think of cancer as a mass of rogue cells that grow uncontrollably. But cancer is more organized and strategic than ...
Tumor cells can lapse into a sleep-like state and thereby evade the destructive effect of cancer drugs. In some types of the ...
The order of cancer-driving mutations—genetic changes—plays an important role in whether tumors in the intestine can develop, new research reveals. These are the findings published on 3 December in ...
Scientists at Pune's Agharkar Research Institute developed a nanomedicine targeting breast cancer cells by silencing key ...
Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have developed immune evasion strategies, leading to poor ...
1don MSN
Why some immunotherapy fails: Tumor-triggered neutrophils can shut down cancer-killing T cells
Certain white blood cells in the immune system, known as neutrophils, can make cancer immunotherapy less effective, according ...
Researchers discovered that mutations linked to blood cancers may help trigger Alzheimer’s disease by creating overly ...
MultiValent Biotherapies, Inc. (MultiValent), a private biotechnology company developing targeted drug conjugate therapies for cancer, announced a $27.425 million first closing of its Series A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results